Literature DB >> 30317878

Exercise intervention attenuates neuropathic pain in diabetes via mechanisms of mammalian target of rapamycin (mTOR).

Xiaohui Ma1, Sitong Liu1, Dongxue Liu1, Qian Wang1, Hongwei Li1, Zhen Zhao2.   

Abstract

This study was to examine the role of exercise intervention in modulating neuropathic pain induced by diabetes. Diabetes was induced by streptozotocin (STZ, i.p.) in rats and mechanical hyperalgesia was observed three weeks after STZ. Mechanical withdrawal thresholds were increased after four to five weeks of exercise in STZ rats. We also examined the role of signal of mammalian target of rapamycin (mTOR) in regulating neuropathic pain. Inhibition of neuropathic pain by exercise in STZ rats was accompanied with decreases of p-mTOR, p-S6K1, and p-4E-BP1 in sensory nerves. Blocking mTOR also elevated mechanical withdrawal thresholds in STZ rats. Furthermore, pro-inflammatory IL-6 was greater in sensory nerves of STZ rats. Inhibition of IL-6 decreased mTOR and increased mechanical withdrawal thresholds in STZ rats. Overall, our data suggest the role played by exercise in improving neuropathic pain after STZ and that IL-6-mTOR signal is a part of mechanisms engaged in the effects of exercise.

Entities:  

Keywords:  Exercise; diabetes; neuropathic pain; peripheral nerve; rapamycin

Mesh:

Substances:

Year:  2018        PMID: 30317878     DOI: 10.1080/13813455.2018.1489851

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  3 in total

Review 1.  Mechanism of exercise-induced analgesia: what we can learn from physically active animals.

Authors:  Joseph B Lesnak; Kathleen A Sluka
Journal:  Pain Rep       Date:  2020-09-23

Review 2.  Exercise and Neuropathic Pain: A General Overview of Preclinical and Clinical Research.

Authors:  Brianna N Leitzelar; Kelli F Koltyn
Journal:  Sports Med Open       Date:  2021-03-22

Review 3.  New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors.

Authors:  Prabhakar Busa; Yaswanth Kuthati; Niancih Huang; Chih-Shung Wong
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.